X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (116) 116
index medicus (103) 103
influenza (91) 91
viruses (80) 80
influenza, human - virology (75) 75
antiviral agents - pharmacology (64) 64
oseltamivir (57) 57
animals (56) 56
infectious diseases (55) 55
virology (53) 53
drug resistance, viral (49) 49
influenza, human - epidemiology (48) 48
microbiology (46) 46
antiviral agents (45) 45
neuraminidase - genetics (43) 43
zanamivir (42) 42
neuraminidase - antagonists & inhibitors (41) 41
influenza a virus, h1n1 subtype - drug effects (40) 40
influenza a virus, h1n1 subtype - genetics (40) 40
influenza, human - drug therapy (40) 40
immunology (37) 37
surveillance (36) 36
influenza viruses (34) 34
pharmacology & pharmacy (34) 34
female (33) 33
oseltamivir - pharmacology (33) 33
virus diseases (33) 33
infection (31) 31
influenza a virus, h1n1 subtype - isolation & purification (30) 30
adult (28) 28
infections (28) 28
adolescent (27) 27
united states - epidemiology (27) 27
antiviral agents - therapeutic use (26) 26
male (26) 26
middle aged (26) 26
drug resistance (25) 25
influenza a virus, h3n2 subtype - genetics (25) 25
mutation (25) 25
neuraminidase inhibitors (25) 25
cell line (24) 24
influenza a virus (24) 24
influenza b virus - drug effects (24) 24
neuraminidase - metabolism (24) 24
public health (24) 24
child, preschool (23) 23
infant (23) 23
influenza a virus, h3n2 subtype - drug effects (23) 23
resistance (23) 23
seasons (23) 23
child (22) 22
enzyme inhibitors - pharmacology (22) 22
influenza b virus - genetics (22) 22
susceptibility (22) 22
dogs (21) 21
health aspects (21) 21
influenza a virus, h3n2 subtype - isolation & purification (21) 21
population surveillance (21) 21
young adult (21) 21
aged (20) 20
analysis (20) 20
influenza b virus - isolation & purification (20) 20
a viruses (19) 19
drug resistance, viral - genetics (19) 19
hemagglutinin (19) 19
medicine (19) 19
pandemics (19) 19
phylogeny (19) 19
influenza a virus - drug effects (18) 18
mice (18) 18
orthomyxoviridae (18) 18
research (18) 18
viral proteins - genetics (18) 18
a virus (17) 17
oseltamivir - therapeutic use (17) 17
vaccines (17) 17
active-site (16) 16
avian influenza (16) 16
public, environmental & occupational health (16) 16
transmission (16) 16
united-states (16) 16
abridged index medicus (15) 15
mice, inbred balb c (15) 15
microbial sensitivity tests (15) 15
neuraminidase inhibitor (15) 15
swine influenza (15) 15
zanamivir - pharmacology (15) 15
antivirals (14) 14
disease outbreaks (14) 14
emergence (14) 14
hemagglutinin glycoproteins, influenza virus - genetics (14) 14
influenza a virus - genetics (14) 14
b viruses (13) 13
epidemics (13) 13
ferrets (13) 13
in-vitro (13) 13
influenza vaccines (13) 13
influenza, human - mortality (13) 13
influenza, human - prevention & control (13) 13
mutations (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 0022-1899, 07/2019
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 09/2017, Volume 216, Issue 6, p. S566
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 09/2019
Abstract Susceptibility of influenza A viruses to baloxavir can be affected by changes at amino acid residue 38 in the polymerase acidic (PA) protein.... 
Journal Article
Analytical Chemistry, ISSN 0003-2700, 03/2017, Volume 89, Issue 5, p. 3130
  Mounting evidence suggests that neuraminidase's functionality extends beyond its classical role in influenza virus infection and that antineuraminidase... 
Influenza | Fluid | Isotopes | Mass spectrometry | Chromatography | Binding sites
Journal Article
Analytical Chemistry (Washington), ISSN 0003-2700, 03/2017, Volume 89, Issue 5, pp. 3130 - 3130
Mounting evidence suggests that neuraminidase's functionality extends beyond its classical role in influenza virus infection and that antineuraminidase... 
Linkages | Receptors | Dilution | Influenza | Viruses | Liquid chromatography | Isotopes | Mass spectrometry
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2017, Volume 65, Issue 10, p. 1644
Background Antigenically drifted A(H3N2) viruses circulated extensively during the 2014-2015 influenza season. Vaccine effectiveness (VE) was low and not... 
Antigens | Immunoglobulins | Effectiveness | Households | Vaccination | Health risks | Viruses | Infections | Vaccines | Antibody response | Confidence intervals | Hemagglutination | Influenza | Exo-a-sialidase | Influenza A | Adults | Inhibition | Children | Influenza B
Journal Article
Virus Research, ISSN 0168-1702, 2004, Volume 103, Issue 1, pp. 199 - 203
A wide use of inhibitors of influenza virus neuraminidase (NAIs) to control influenza in humans demands a better understanding of the mechanisms involved in... 
Neuraminidase inhibitor | Drug resistance | Immunocompromised patients | HEMAGGLUTININ | ACTIVE-SITE | IN-VITRO SELECTION | 4-GUANIDINO-NEU5AC2EN | OSELTAMIVIR | A VIRUS | neuraminidase inhibitor | VIROLOGY | HOST-CELL | immunocompromised patients | drug resistance | HIGHLY POTENT | RECEPTOR SPECIFICITY | BINDING
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 25, pp. 2616 - 2625
Journal Article
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2012, Volume 17, Issue 1, pp. 159 - 173
Infection with influenza viruses, including seasonal, avian and pandemic viruses, remains a worldwide public health problem. Although influenza virus infection... 
INFECTIOUS DISEASES | A H1N1 | ACTIVE-SITE | DRUG-RESISTANCE | PANDEMIC H1N1 2009 | B VIRUSES | VIROLOGY | IMMUNOCOMPROMISED PATIENTS | ANTIVIRAL RESISTANCE | OSELTAMIVIR-RESISTANT | PHARMACOLOGY & PHARMACY | ZANAMIVIR RESISTANCE | REDUCED SENSITIVITY
Journal Article
Journal Article